Recent Advances in the Biology of Heavy-Ion Cancer Therapy
Open Access
- 1 January 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 51 (4), 365-383
- https://doi.org/10.1269/jrr.09137
Abstract
Superb biological effectiveness and dose conformity represent a rationale for heavy-ion therapy, which has thus far achieved good cancer controllability while sparing critical normal organs. Immediately after irradiation, heavy ions produce dense ionization along their trajectories, cause irreparable clustered DNA damage, and alter cellular ultrastructure. These ions, as a consequence, inactivate cells more effectively with less cell-cycle and oxygen dependence than conventional photons. The modes of heavy ion–induced cell death/inactivation include apoptosis, necrosis, autophagy, premature senescence, accelerated differentiation, delayed reproductive death of progeny cells, and bystander cell death. This paper briefly reviews the current knowledge of the biological aspects of heavy-ion therapy, with emphasis on the authors' recent findings. The topics include (i) repair mechanisms of heavy ion–induced DNA damage, (ii) superior effects of heavy ions on radioresistant tumor cells (intratumor quiescent cell population, TP53-mutated and BCL2-overexpressing tumors), (iii) novel capacity of heavy ions in suppressing cancer metastasis and neoangiogenesis, and (iv) potential of heavy ions to induce secondary (especially breast) cancer.Keywords
This publication has 99 references indexed in Scilit:
- Ionizing radiation downregulates ASPM, a gene responsible for microcephaly in humansBiochemical and Biophysical Research Communications, 2008
- In vitro irradiation of basement membrane enhances the invasiveness of breast cancer cellsBritish Journal of Cancer, 2007
- Inhibition of homologous recombination repair in irradiated tumor cells pretreated with Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycinBiochemical and Biophysical Research Communications, 2006
- Targeting Bcl-2 and Bcl-XL with nonpeptidic small-molecule antagonistsSeminars in Oncology, 2003
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Level of DNA Double-strand Break Rejoining in Chinese Hamsterxrs-5 Cells is Dose-dependent: Implications for the Mechanism of RadiosensitivityInternational Journal of Radiation Biology, 1992
- Use of the Micronucleus Assay for the Selective Detection of Radiosensitivity in BUdR-unincorporated Cells after Pulse-labelling of Exponentially Growing Tumour CellsInternational Journal of Radiation Biology, 1990
- Production and Repair of Chromosome Damage in an X-ray Sensitive CHO Mutant Visualized and Analysed in Interphase Using the Technique of Premature Chromosome CondensationInternational Journal of Radiation Biology, 1990
- X-Ray—Induced Breakage and Rejoining of Human Interphase ChromosomesScience, 1983
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971